HIV

News

Group of young multiracial woman with red ribbons in hands are struggling against HIV/AIDS. AIDS awareness concept.

ViiV hopes for blockbuster with HIV drug combo approval

The FDA has approved ViiV’s Dovato, a single-tablet, two drug HIV drug regimen of dolutegravir and lamivudine for treatment-naïve patients, making it the only company to have such a drug on

Views & Analysis

R&D round-up: Non-opioid painkiller space heats up

As the MHRA announced that it would be convening an Expert Working

News

Once-a-month HIV treatment sees promising phase III results

Janssen and ViiV have reported positive data for their once-monthly injectable HIV combo regimen in two phase III trials.

Sales & Marketing

Are dual ARVs the new frontier in a maturing HIV market?

Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and

News

J&J builds case for HIV vaccine ahead of pivotal trial reado...

Johnson & Johnson has moved a step closer to the goal of developing a vaccine that can help prevent HIV infection, thanks to positive data from a phase 1/2a trial.

News